PMG, Inc.

HealthITAnalytics | February 10, 2020

A team of scientists from Purdue University and other research institutions around the world leveraged data mining techniques to better understand trends in the gene therapy field in respect to nonviral vectors. With the global gene therapy market expected to reach $13 billion by 2024, researchers are seeking to understand as much as they can about how these treatment can target cancer and other diseases. Purdue scientists joined forced with researchers from around the globe to learn more about ...

HEALTH TECHNOLOGY

Charles River Laboratories | September 20, 2021

Charles River Laboratories International, Inc.today released the results from its first annual Healthcare Collaboration Report, which identified Americans’ perceptions of healthcare’s strengths and weaknesses, general knowledge of drug and vaccine development, as well as respondents’ key future priorities. The survey, conducted in May of 2021 with The Harris Poll, polled more than 1,500 Americans and found respondents want to see industry players working together, with 64% s...

EHRIntelligence | March 16, 2020

The spread of the COVID-19 pandemic has put the importance of health data exchange and interoperability under a microscope. Niam Yaraghi, a fellow in governance studies at the Center for Technology Innovation at Brookings Institution, penned an op-ed to explain why he thinks the US lacks health information technologies to stop or contain the COVID-19 epidemic. The pandemic has shattered our common beliefs about the type and scope of health information exchange (HIE), wrote Yaraghi. “It has...

Healthcare IT News | April 02, 2020

When healthcare experts in Europe started debating whether or not to reimburse digital health applications two years ago, Josef Hecken, a very senior German health politician, said in an interview that health insurance companies should not be obliged to pay for “fun applications”. Hecken is head of the German healthcare system’s governing board for reimbursement decisions (G-BA). He is among those who really has a say on where the money flows in German healthcare. Quotes ...